Managing the progression of lower urinary tract symptoms/benign prostatic hyperplasia: therapeutic options for the man at risk

There are two fairly divergent reviews in this month’s issue. The first is a paper which concentrates on the progression of LUTS and BPH. Previous papers on LUTS and BPH were focused on changes in urinary flow rates and symptom scores, a rather static view of things. The first author in this review...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BJU international 2007-08, Vol.100 (2), p.249-253
Hauptverfasser:	Emberton, Mark, Zinner, Norman, Michel, Martin C., Gittelman, Marc, Chung, Moon‐Kee, Madersbacher, Stephan
Format:	Artikel
Sprache:	eng
Schlagworte:	5-alpha Reductase Inhibitors 5α‐reductase inhibitor Adrenergic alpha-Antagonists - therapeutic use benign prostatic hyperplasia combined therapy dihydrotestosterone Dihydrotestosterone - metabolism Disease Progression Humans Male prostate volume Prostatic Hyperplasia - complications Prostatic Hyperplasia - drug therapy Prostatism - drug therapy Prostatism - etiology Risk Factors Treatment Outcome α‐blocker
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!